Why IMV Stock Is Getting Hammered

IMV Ord Shs IMV shares are trading lower Friday morning after the company announced a $9 million registered direct offering price at-the-market under Nasdaq rules.

What Else?

IMV says the company intends to use the net proceeds from the Offering to continue the clinical development of its lead product candidate, maveropepimut-S, in diffuse large B cell lymphoma (DLBCL), ovarian cancer, the completion of its ongoing basket trial and to continue the development of its proprietary drug delivery platform (DPX®) and for general corporate purposes.

The offering is expected to close on or about December 20, subject to the satisfaction of customary closing conditions.

See Also: As Tesla Extends Discounts To Europe, Rival Ford Hikes F-150 Lightning Prices For 3rd Time Since Launch

According to data from Benzinga Pro, IMV is trading lower by 24.7% to $2.74.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Penny StocksMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!